Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B

Clinical trial NCT02249988 · COMPLETED

Trial details

NCT number: NCT02249988
Sponsor: Abivax S.A.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2014-12-01
Primary completion: 2016-12-01
Enrollment: 261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.